Leading AI CEOs and biosecurity experts have signed an open letter urging Congress to mandate federal screening and recordkeeping for all commercial gene synthesis orders to prevent misuse.

Key Points

• Signatories include OpenAI’s Sam Altman, Google DeepMind’s Demis Hassabis, and Anthropic’s Dario Amodei, alongside 85 other experts.
• The letter advocates for mandatory screening of synthetic DNA orders to prevent the creation of dangerous pathogens or biological weapons.
• Current screening is largely voluntary, creating a security gap where bad actors could exploit providers with lax standards.
• Proponents support the bipartisan Biosecurity Modernization and Innovation Act, which would task the Department of Commerce with establishing new screening rules.
• Experts suggest using AI-driven defensive tools to identify and block high-risk genetic sequences before they are manufactured.

Why it Matters

This rare alignment among competing AI leaders highlights a growing consensus that AI could lower the barrier for bad actors to design and synthesize harmful biological agents. By pushing for standardized, mandatory screening, the industry aims to establish a critical safety checkpoint that mitigates catastrophic risks while preserving the benefits of legitimate medical and scientific research.